default author photo

Andrea Botti

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

3

DOWNLOADS

62

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Locally Advanced Nsclc: Overview of Real-World Pattern of Recurrence in Durvalumab Era (Leopard Trial)

Number of pages: 17 Posted: 05 Jun 2025
Patrizia Ciammella, Federico Iori, Paolo Borghetti, Marco Galaverni, Emanuele Alì, Marcello Tiseo, Maria Pagano, Matteo Sepulcri, Vieri Scotti, Niccolò Giaj-Levra, Michela Marcenaro, Nicola Simoni, Andrea Botti, Valerio Nardone, Salvatore Cozzi and Alessio Bruni
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Ospedale Sacro Cuore Don Calabria, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland and affiliation not provided to SSRN
Downloads 27 (1,359,097)

Abstract:

Loading...

non-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy, salvage therapy, SBRT, PACIFICnon-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy

2.

The Role of Low-Dose Radiotherapy in Managing Primary Indolent Cutaneous B-Cell Lymphomas: A Multicenter Retrospective Study

Number of pages: 14 Posted: 01 Oct 2025
Emanuele Alì, Gabriele Simontacchi, Mario Levis, Federico Iori, Silvia Gambara, Erica Cuffini, Nicola Pimpinelli, Vieri Scotti, Andrea Botti, Giulia Paolani, Cinzia Iotti, Umberto Ricardi and Patrizia Ciammella
affiliation not provided to SSRN, University of Florence - Azienda Ospedaliero Universitaria Careggi, University of Turin, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, University of Florence, University of Florence, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin and affiliation not provided to SSRN
Downloads 18 (1,470,786)

Abstract:

Loading...

low-dose radiotherapy, Primary Indolent Cutaneous B-Cell Lymphomas, Lymphomas, Cutaneous Lymphomas, Radiotherapy, B-Cell Lymphomas, Indolent Lymphomas

3.

EPID In Vivo Dosimetry for Assessing IGRT Protocol Selection in Breast Cancer

Number of pages: 18 Posted: 24 Jun 2026
Elisabetta Cagni, Valeria Trojani, Farah Emad Abdallah Jadallah, Maria Grazia Laturra, Laura Verzellesi, Francesco Braglia, Ayman El Ouati, Andrea Botti, Antonella Ferrarini, Nadia Moretti, Alice Zamagni, Raffaele Cardano, Cinzia Iotti, Mauro Iotti and Marco Esposito
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Università di Bologna, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 17

Abstract:

Loading...

EPID in vivo dose (EIVD), IGRT protocol, breast cancer radiotherapy, Tumor Control Probability (TCP), Lifetime attributable risk (LAR)